To the Editor The recent article by Kravitz and colleagues1 reporting the results of a randomized clinical trial comparing n-of-1 trials with standard care for treatment of chronic musculoskeletal pain raises a number of interesting issues that merit further examination.
Weighed on a continuum of probability, it is certainly possible that there is a positive effect of these trials on pain interference score, which is unlikely to be because of chance alone based on the observed results; however, this effect is not demonstrated to the arbitrary level that is customary for statistical significance. This speaks directly to 2 points: (1) the P value standards we set are subjective and should be viewed not as dichotomous yes/no evidence, but as a continuum of probability as put forth in the American Statistical Association statement on P values,2 and (2) the clinical significance of the findings of this trial are ignored in favor of identifying statistical superiority for pain-interference score. The stated goal of the authors was to establish the “benefits of participating in an n-of-1 trial, not to assess the superiority or inferiority of any particular treatment.”1(1369) The improvement in shared decision making regarding medications is perhaps even more meaningful than a narrow statistical focus on pain interference score as an outcome owing to the mistrust of health care professionals that has become pervasive in the medical system and litigation that is a prominent feature of US medicine.
Identify all potential conflicts of interest that might be relevant to your comment.
Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.
Err on the side of full disclosure.
If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.
Not all submitted comments are published. Please see our commenting policy for details.
Chapple AG, Blackston JW. Finding Benefit in n-of-1 Trials. JAMA Intern Med. 2019;179(3):453–454. doi:10.1001/jamainternmed.2018.8379
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.